New Treatment of Head and Neck Cancer by Oncolytic Recombinant Sendai Virus

2016 ◽  
Vol 67 (2) ◽  
pp. 128-128
Author(s):  
Y. Miyagawa ◽  
T. Yamashita ◽  
S. Tanaka ◽  
Y. Tanaka ◽  
M. Tomifuji ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Sendai Virus ◽  
New Treatment

Arginine deprivation as a new treatment strategy for head and neck cancer

Oral Oncology ◽  
2012 ◽  
Vol 48 (12) ◽  
pp. 1227-1235 ◽  
Author(s):  
Cheng-Chih Huang ◽  
Sen-Tien Tsai ◽  
Ching-Chuan Kuo ◽  
Jeffrey S. Chang ◽  
Ying-Tai Jin ◽  
...  
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Treatment Strategy ◽  
Arginine Deprivation ◽  
New Treatment

New treatment strategies for HPV-positive head and neck cancer

2013 ◽  
Vol 271 (7) ◽  
pp. 1861-1867 ◽  
Author(s):  
B. Kofler ◽  
S. Laban ◽  
C. J. Busch ◽  
B. Lörincz ◽  
R. Knecht
Keyword(s):  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Treatment Strategies ◽  
New Treatment

scholarly journals Access to Optimal Treatment in Head and Neck Cancer: A Patient Perspective

2017 ◽  
Vol 1 ◽  
pp. maapoc.0000014
Author(s):  
Chris Curtis
Keyword(s):  
Quality Of Life ◽  
Health Care ◽  
Head And Neck Cancer ◽  
Head And Neck ◽  
Neck Cancer ◽  
Personal Perspective ◽  
Timely Access ◽  
Long Time ◽  
New Treatment

Introduction Head and neck cancer is a life-changing disease affecting all aspects in the life of a patient; eating, swallowing, talking, and socializing become very hard to deal with and comprehensive support is essential, regardless of the person's gender, age, social status, or background. The aim of this article is to describe the journey of a patient from a clinical and personal perspective, while discussing the importance of timely access to the most appropriate treatment based on outcome and on the patient's quality of life. Case presentation The journey of a head and neck cancer patient is illustrated from his own perspective. The clinical case also highlights a few key issues on medicine access. First, it has been a long time since any new treatment or drugs have been available to treat head and neck cancer patients, although the scenario might change drastically due to the introduction of immunotherapy. Second, it is unusual that even the most caring health care professional would consider a treatment that is not licensed in their country, even if it would have made a significantly positive difference to the patient's quality of life. Conclusions The increasing patient and health care professional's awareness of a solution to their problem with the use of unlicensed treatment, and the decreasing burden linked to identifying and sourcing unlicensed treatment, should help to optimize the management of these patients and significantly impact the outcome and their quality of life.

Sign in / Sign up

Export Citation Format

Share Document